|

Iguratimod Clinical Trials

2 actively recruiting trials

Also known as: IGU, T-614, tofacitinib

Pipeline

Phase 4: 2

Top Sponsors

  • Yanfeng Hou1
  • Qilu Hospital of Shandong University1

Indications

  • Arthritis2
  • Therapy1
  • Arthritis, Rheumatoid1
  • Rheumatoid Arthritis1

Other2 trials

Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis
Phase 4
The Clinical Efficacy of Immunomodulators in RA Patients
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.